Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Our AI drug discovery platform leverages public and proprietary biomedical data and features the world’s leading knowledge graph for rare diseases. Combining this technology with patient insights and drug discovery expertise, our mission is to advance 100 rare disease treatments towards the clinic by 2025.
Total Funding: $67.9M
Funding Stage: Series B
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 26 to 50
Founded: 2014
Apr 2021
- Healx Launches Partnership with Ataxia UK and FARA to Find Treatments for Rare Neurodegenerative Condition
Mar 2021
- Healx and The PKD Charity Collaborate to Apply AI to the Discovery of Novel Treatments for Rare Kidney Diseases
Aug 2017
- Healx Data Scientist Wins Poster Prize for Finding New Links Between Rare Diseases
Machine Learning Engineer
Cambridge, England
VP of Engineering
Cambridge, England
Senior Computational Systems Biologist (Bioinformatician)
Cambridge, England
Scientific Programmer
Cambridge, England
Principal Pharmacologist
Cambridge, England
